Category: United States
-
AstraZeneca faces fresh mRNA patent infringement allegations in District of Delaware
Gene-editing tech company Factor Bioscience has sued AstraZeneca and its affiliate Cellectis over the infringement of three mRNA-related patents.
-
Starbucks invokes anti-patent-troll state law in major defensive complaint against Key Patent Innovations and its shell company
This is one of the most notable prophylactic patent-related lawsuits because it takes aim at a non-practicing entity’s shell company from multiple angles.
-
Via LA announces semiconductor memory patent pool program: first in series of semiconductor-related licensing programs
Via Licensing Alliance has announced plans to launch a patent pool program dedicated to licensing semiconductor memory technologies, as part of a new series of programs that will span the semiconductor industry.
-
Federal Circuit partly grants Bayer second chance in defending rivaroxaban patent invalidation campaign
The Federal Circuit has partly affirmed and partly vacated a United States Patent and Trademark Office’s Patent Trial and Appeal Board decision that deemed one of Bayer’s rivaroxaban-related patents invalid, in a three-year case initiated by rivals Mylan Pharmaceuticals, Teva Pharmaceuticals, and Invagen Pharmaceuticals.
-
Headwater launches fresh cloud messaging patent infringement campaign: Tencent, Uber, Target, Walmart among defendants
The patent infringement campaign appears to be targeting Google customers, as the complaints all refer to the company’s Firebase Cloud Messaging, and it asserts a patent also involved in a recently-settled dispute with Samsung Electronics.
-
American Express handed win in loyalty program patent infringement dispute
A U.S. district court has granted a motion to dismiss a complaint filed by Loyal-T Systems LLC against American Express for failing to state a claim for relief.
-
Moderna, Alnylam settle U.S. COVID vaccine patent infringement dispute
Alnylam has settled its three-year dispute against Moderna in the District of Delaware, after a precedential Federal Circuit decision found the patentee had acted as its own lexicographer in defining a key patent specification term, foreclosing its infringement allegations.
-
Samsung, Headwater settle wireless patent dispute
Samsung and Headwater Research have settled a two-year patent infringement dispute.
-
Regeneron makes strides in global Eylea patent enforcement campaign: settles with Sandoz, files fresh UK suits
Regeneron has settled its year-long patent infringement dispute with Sandoz over several patents related to its eye disease drug Eylea, and filed a fresh lawsuit against two more rivals over the same drug in the High Court of Justice for England & Wales.
-
Pfizer, BioNTech hit back against GSK mRNA suits in UPC, Ireland: file UK revocation action
The move does not come as a major surprise, given the pharma companies’ previous success against GlaxoSmithKline in the UK.